Health & Safety

August 10, 2012

Laboratory developed tests covered under TRICARE demonstration may help guide cancer treatment decisions

by TRICARE Public Affairs

Some TRICARE beneficiaries will soon be able to take advantage of new technologies aimed at helping patients and healthcare providers make more informed decisions regarding treatment options for surgery, chemotherapy or radiation therapy for some types of cancer.

On May 22, 2012, two laboratory developed tests were approved for coverage by TRICARE under a demonstration project: the BRACAnalysis BRCA1 and BRCA2 tests (Myriad Genetic Laboratories, Inc.), and also, the Oncotype DX Breast Cancer Assay (Genomic Health, Inc.).

BRACAnalysis testing assesses a woman’s risk of developing hereditary breast or ovarian cancers based on detection of mutations in their BRCA1 and BRCA2 genes. The Oncotype DX breast cancer assay is a test that examines a breast cancer patient’s tumor tissue at the molecular level; specifically, it is hoped that this information can help individualize the planning of the patient’s breast cancer treatment. The complete description of this demonstration project is available at www.gpo.gov/fdsys/pkg/FR-2011-12-27/html/2011-33066.htm.

The criteria for which of these tests will be covered by TRICARE are scheduled to be published in the TRICARE Operations Manual in August 2012. TRICARE providers will be prepared to accept patients under the demonstration project by September 30, 2012; however, coverage for the approved use of these tests is retroactive to May 22, 2012. Beneficiaries should speak with their primary health care professional or their regional contractor to determine their eligibility for having these tests performed as a TRICARE benefit. Find regional contractor contact information at www.tricare.mil/contactus.




All of this week's top headlines to your email every Friday.


 
 

 
MG-appointments

Don’t be a no show

The 412th Medical Group is dedicated to meeting the health care needs of you and your family by providing access to its services and the best possible medical care. No shows are a costly problem for the 412th MDG and the patie...
 
 

DOD brain injury experts give prevention tips for Motorcycle Safety Awareness Month

Timely advice focuses on motor vehicle collisions, leading cause of military brain injuries As part of efforts to promote safe driving during Motorcycle Safety Awareness Month, experts from the Defense and Veterans Brain Injury Center’s A Head for the Future initiative remind drivers to protect their heads while on the road. Motor vehicle collisions are...
 
 

Beat the heat through Wet Bulb Globe Temperature Index

As a safety professional and working here at Edwards AFB in the summer, you are at the mercy of the heat. Because of the heat, I will discuss the Wet Bulb Globe Temperature. The WBGT combines four thermal components: ambient air temperatures, relative humidity, air velocity and radiant heat. At Edwards, heat related incidents can...
 

 

On-the-job falls affect work productivity

It is a fact that more than 16 percent of all falls on the job result in injuries affecting the productive environment of the workplace. It becomes essential to implement a means to prevent falls while at the workplace. There are basically two kinds of falls: those that happen in single-story structure and those that...
 
 

Teal Helping Hands

Air Force photograph The Teal Helping Hands display, currently at the Oasis Community Center, is a traveling wall project presented by the 412th Test Wing’s Sexual Assault Prevention Office. The display will also head to Bldg. 3000 next to close out Sexual Assault Prevention Month.   Throughout the month of April, which is Sexual Assault...
 
 
Air Force photograph by Kenji Thuloweit

‘Motorcycles are everywhere’

Air Force photograph by Kenji Thuloweit Always be on the lookout for motorcycles while driving. Have you noticed more motorcyclists on the road lately? Have you looked for motorcyclists while driving? After a multi-vehicle acci...
 




0 Comments


Be the first to comment!


Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>